PRQR
ProQR Therapeutics BV
NASDAQ: PRQR · HEALTHCARE · BIOTECHNOLOGY
$1.57
+1.95% today
Updated 2026-04-30
Market cap
$155.93M
P/E ratio
—
P/S ratio
9.54x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$1 – $3
Volume
0.6M
ProQR Therapeutics BV (PRQR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-258.00%
Operating margin
-192.90%
ROE
-61.20%
ROA
-19.40%
Debt/equity
0.29x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $30000.00 | — | — | — | — |
| 2013 | $160000.00 | $-3.25M | 72.50% | -2,024.37% | -2,033.13% |
| 2014 | $313000.00 | $-12.13M | 100.00% | -5,259.11% | -3,874.44% |
| 2015 | $9.41M | $-20.83M | 94.87% | -287.05% | -221.45% |
| 2016 | $2.28M | $-39.10M | 43.84% | -1,734.14% | -1,713.54% |
| 2017 | $-1.53M | $-43.64M | 165.49% | 2,648.66% | 2,853.96% |
| 2018 | $4.94M | $-36.89M | 80.09% | -734.53% | -746.69% |
| 2019 | $1.93M | $-56.75M | -5,943.61% | -2,971.81% | -2,935.64% |
| 2020 | $1.03M | $-46.56M | 100.00% | -4,117.40% | -4,525.27% |
| 2021 | $1.33M | $-60.74M | 100.00% | -4,285.39% | -4,549.81% |
| 2022 | $3.59M | $-64.42M | 100.00% | -1,812.99% | -1,792.54% |
| 2023 | $6.51M | $-28.12M | 100.00% | -489.09% | -431.67% |
| 2024 | $18.91M | $-27.76M | 100.00% | -161.18% | -146.86% |
| 2025 | $15.28M | $-40.52M | 83.01% | -275.91% | -265.21% |